Kazuhiko Takehara

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +4

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

Otylia Kowal‐Bielecka, Robert Landewé, Jérôme Avouac et al. · Annals of the Rheumatic Diseases · 2009 · 617 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +11

Role and interaction of connective tissue growth factor with transforming growth factor-? in persistent fibrosis: A mouse fibrosis model

Toshifumi Mori, Shigeru Kawara, Mikio Shinozaki et al. · Journal of Cellular Physiology · 1999 · 465 citations

Veterinary Medicine, Pathobiology, Pathology +16

Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders

Atsuyuki Igarashi, Kiyoko Nashiro, Kanako Kikuchi et al. · Journal of Investigative Dermatology · 1996 · 437 citations · Full text

Medicine, Dermatology, Pathology +9

Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome

Yasuhito Hamaguchi, Manabu Fujimoto, Takashi Matsushita et al. · PLoS ONE · 2013 · 395 citations · Full text

Life Sciences, Dermatology, Immunology +16